HAUSP inhibitors in p53-wild type and p53-mutant tumors

Tammy A Morrish

Mechanisms of Subtelomere Recombination in Telomerase Deficient Tumors

Non-Hodgkin lymphoma

Kenneth Lynn Wright

Natural Killer Cell Regulation by PRDM1 and IRF4/8

Non-Hodgkin lymphoma

Daniel M Sullivan

CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS

Multiple myeloma and immunoproliferative diseases

Yves Pommier

DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs

Colorectum

Margaret A Goodell

A Mouse Model of DNMT3A-Associated Hematologic Malignancy

Non-Hodgkin lymphoma

Irene M. Ghobrial

Stroma-mediated clonal evolution in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Carl F Ware

HVEM-BTLA Pathway in Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Shahinaz Gadalla

Myotonic Dystrophy Tumorigenesis: Risk Factors and Molecular Mechanisms

Colorectum

Hans Schreiber

Immunology of Unique Tumor Specific Antigens

Colorectum